We are honored to have given our first official pitch with Transire Bio at the top 50 of W.A. De Vigier Award. We were selected among 310 applicants and we will have a chance to pitch in Soloturn in the Life Sciences & Biotech & Pharma cluster.

Read the press release at https://devigier.ch/press-release-selection-day-top50-2023/. Learn more about Bil De Vigier and W.A. De Vigier Foundation at https://devigier.ch/.